decitabine, cytarabine, and daunorubicin hydrochloride
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for decitabine, cytarabine, and daunorubicin hydrochloride, covering 2026-04-27 to 2026-04-27. Get the full timeline:
Most recent: Clinical Trial Update: Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia [Phase 2]